Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 1 Dec 2017
S Winterhalter, A Eckert, GA Vom Brocke, A Schneider, D Pohlmann, D Pilger, AM Joussen, M Rehak and U Grittner
To evaluate the therapeutic outcome for dexamethasone implant (DEX) or intravitreal ranibizumab (IVR) injections over 6 months in patients with macular edema due to branch or central retinal vein occlusion (BRVO, CRVO), in a real-life setting.
* Data courtesy of Altmetric.com